52-week Open Label Safety-Tolerability Study
for Schizophrenia
Sites in Canton +22 more locations
Sponsor: LB Pharmaceuticals Inc.
Sex: All·Age: 18 - 65
Code: NCT07369154·Phase 3·Recruiting·Listed Jan 2026
Paid Clinical Trials in Canton, OH
As of September 2026, 150 paid clinical trials are recruiting in Canton, Ohio. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Filter results
143 clinical trials
Get a weekly email when new trials open in Canton, OH.
Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
for Atopic Dermatitis (AD)
Sites in Canton, Mayfield Heights +30 more locations
Sponsor: Enveda Therapeutics
Sex: All·Age: 18 - 75
Code: NCT07298395·Phase 2·Recruiting·Listed Dec 2025
A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy
for Gastrointestinal Neoplasms
Sites in Canton, Columbus +46 more locations
Sponsor: GlaxoSmithKline
Sex: All·Age: 18+
Code: NCT07218926·Phase 3·Recruiting·Listed Oct 2025
A Study to Investigate the Safety and Preliminary Efficacy of GSK5460025 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors
for Neoplasms, Colorectal
Sites in Canton +3 more locations
Sponsor: GlaxoSmithKline
Sex: All·Age: 18+
Code: NCT07213609·Phase 1, Phase 2·Recruiting·Listed Oct 2025
DESTINY-PANTUMOUR04
for Adenocarcinoma (NOS)
Sites in Canton, Maumee +16 more locations
Sponsor: AstraZeneca
Sex: All·Age: 18 - 130
Code: NCT07124000·Recruiting·Listed Aug 2025
Imeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
for Chronic Inflammatory Demyelinating Polyneuropathy
Sites in Canton +32 more locations
Sponsor: Immunovant Sciences GmbH
Sex: All·Age: 18+
Code: NCT07032662·Phase 2·Recruiting·Listed Jun 2025
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
for Heart Failure
Drug: Dapagliflozin
Sites in Canton, Columbus +169 more locations
Sponsor: AstraZeneca
Sex: All·Age: 40+
Code: NCT06677060·Phase 3·Recruiting·Listed Nov 2024
Observational Study Protocol: LIVER-R
for Hepatobiliary Cancers
Sites in Canton +23 more locations
Sponsor: AstraZeneca
Sex: All·Age: 18 - 130
Code: NCT06252753·Recruiting·Listed Feb 2024
Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma
for Endometrial Carcinoma
Sites in Canton, Parma +326 more locations
Sponsor: National Cancer Institute (NCI)
Sex: Female·Age: 18+
Code: NCT05256225·Phase 3·Recruiting·Listed Feb 2022
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
for Chronic Kidney Disease and Hypertension
Drug: Dapagliflozin
Sites in Canton, Columbus +115 more locations
Sponsor: AstraZeneca
Sex: All·Age: 18+
Code: NCT06742723·Phase 3·Recruiting·Listed Dec 2024
A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
for Graves' Disease
Drug: IMVT-1402
Sites in Canton +54 more locations
Sponsor: Immunovant Sciences GmbH
Sex: All·Age: 18 - 75
Code: NCT06727604·Phase 2·Recruiting·Listed Dec 2024
A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments
for Multiple Myeloma
Sites in Canton +10 more locations
Sponsor: GlaxoSmithKline
Sex: All·Age: 18+
Code: NCT05714839·Phase 1, Phase 2·Recruiting·Listed Feb 2023
A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism
for Tumor Hyperinsulinism (Tumor HI)
Sites in Canton +7 more locations
Sponsor: Rezolute
Sex: All·Age: 18+
Code: NCT06881992·Phase 3·Recruiting·Listed Mar 2025
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Non-Squamous NSCLC
for Non-squamous Non-small Cell Lung Cancer
Drug: Rilvegostomig
Sites in Canton +60 more locations
Sponsor: AstraZeneca
Sex: All·Age: 18+
Code: NCT06627647·Phase 3·Recruiting·Listed Oct 2024
Study of BHV-1300 in Graves' Disease
for Graves Disease
Sites in Canton +9 more locations
Sponsor: Biohaven Therapeutics Ltd.
Sex: All·Age: 18 - 65
Code: NCT06980649·Phase 1·Recruiting·Listed May 2025
A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer
for Carcinoma, Non-Small Cell Lung
Drug: Rilvegostomig
Sites in Canton +38 more locations
Sponsor: AstraZeneca
Sex: All·Age: 18+
Code: NCT06868277·Phase 3·Recruiting·Listed Mar 2025
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
for Metastatic Head and Neck Squamous Cell Carcinoma
Sites in Canton, Cleveland +48 more locations
Sponsor: Bicara Therapeutics
Sex: All·Age: 18+
Code: NCT06788990·Phase 2, Phase 3·Recruiting·Listed Jan 2025
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS
for Acute Coronary Syndrome
Sites in Canton, Cleveland +146 more locations
Sponsor: DalCor Pharmaceuticals
Sex: All·Age: 45+
Code: NCT05918861·Phase 3·Recruiting·Listed Jun 2023
A Study of Momelotinib in Participants With Low-risk Myelodysplastic Syndrome
for Myelodysplastic Syndromes
Sites in Canton +5 more locations
Sponsor: GlaxoSmithKline
Sex: All·Age: 18+
Code: NCT06847867·Phase 2·Recruiting·Listed Feb 2025
A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma
for Neoplasms, Head and Neck
Drug: Dostarlimab
Sites in Canton +30 more locations
Sponsor: GlaxoSmithKline
Sex: All·Age: 18+
Code: NCT06256588·Phase 3·Recruiting·Listed Feb 2024